INTRODUCTION
============

*In vivo* quantification of opioid receptors (ORs) and changes in their distribution and availability in the central nervous system (CNS) following neurodegenerative diseases, substance abuse and nociceptive signaling is crucial for precise diagnosis and therapy monitoring (for review see: Henriksen and Willoch, 2008 \[[@R1]\]). Three well-defined subtypes of cerebral ORs with different functional properties are known: μ-,δ- and κ-OR (Knapp et al., 1995) \[[@R2]\], Connor and Christie, 1999) \[[@R3]\]. A number of tracers have been developed for imaging of opioid receptors with positron emission tomography (PET) (Henriksen and Willoch) \[[@R1]\], Henriksen et al., 2006 \[[@R4]\], however only the δ-OR-selective \[^11^C-methyl\]naltrindole and the µ-OR-selective \[^11^C\]carfentanil depict single subclasses of the ORs in humans.

11C-labeled carbamate (-)-4-methoxycarbonyl-2-\[(1-pyrrolidinylmethyl\]-1-\[(3,4-dichlorophenyl)acetyl-piperidine (\[^11^C\] GR103545) is a promising PET tracer for imaging of the κ-OR. Dynamic studies with \[^11^C\]GR103545 in baboons demonstrated high κ-OR affinity, excellent brain penetration, rapid uptake and wash-out kinetics, and low degree of non-specific binding (Talbot *et al.*, 2005 \[[@R5]\]).

The reported radiosynthesis of \[^11^C\]GR103545 relies on reduction of cyclotron produced \[^11^C\]carbon dioxide to form \[^11^C\]methanol, treatment with phosgene to produce \[^11^C\]methyl chloroformate, and subsequent reaction with the amine precursor to provide the 11C-labeled carbamate group (Ravert *et al.*, 1999 \[[@R6]\]; (Ravert *et al.*, 2002) \[[@R7]\]. Unfortunately, the method provides low radiochemical yields (RCY) in the range of 2 (Talbot *et al.* 2005) to 14% (Ravert *et al.*, 2002) \[[@R7]\]. Together with the large variations in the specific activity obtained (2564 mCi/µmol (Ravert *et al.*, 2002) \[[@R7]\], 150-495 mCi/µmol (Talbot *et al.* 2005 \[[@R5]\]), it is indicated that this method is capricious and thus effectively preventing human studies with \[^11^C\]GR103545.

Here we report a new method for radiosynthesis of ^11^C-carbamate groups based on *in situ* reaction of amines with carbon dioxide and subsequent ^11^C-methylation of the carbamino adduct. As the method only requires a single radioactive step, the entire process of labeling, purification and product formulation can readily be carried out using an automated synthesis module.

In the initial part of the study, the carbamation of benzylamine **[1](#S1){ref-type="scheme"}** was formed by reaction with CO~2~ in the presence of Cs2CO3 and tetrabutyl ammonium iodide (TBAI). ^11^C-Methylation with \[^11^C\]CH~3~I under conditions similar to those reported for formation of non-radioactive carbamates (Salvatore *et al.,* 2001 \[[@R8]\]) provided carbamate **2** (Table **[1](#T1){ref-type="table"}**) in 18-36% radiochemical yield (RCY) \[[@R9]\]. Attempts to improve the radiochemical yield by heating the reaction mixture resulted in formation of N-\[^11^C-methyl\]benzylamine (**3**) \[[@R10]\] in addition to the desired \[^11^C\]carbamate **2**. The reduced chemoselectivity of the reaction at elevated temperature may be due to decomposition of the carbamino adduct and subsequent *N*-alkylation of the free amine as outlined in Scheme **[1](#S1){ref-type="scheme"}**.

Because of the apparent instability of the carbamino adduct at higher temperature, methylation with the more reactive \[^11^C\]methyl-triflate (\[^11^C\]CH~3~OTf) \[[@R11]\] was evaluated. Initial experiments with \[^11^C\]CH~3~OTf were performed under identical conditions to those used for alkylation with \[^11^C\]CH~3~I. Also in these experiments, the N-methylated side product **3** was observed when the reaction was carried out at elevated temperatures. We speculated that the large excess of iodide in the reaction mixture, resulting from addition of TBAI, may react with \[^11^C\]CH~3~OTf to form \[^11^C\]CH~3~I *in situ*. Substituting the phase-transfer catalyst with tetrabutyl ammonium triflate (TBAOTf) resulted in RCYs in the range of 69 ± 8 to 91 ± 5% within 2 min at 25 and 40°C, respectively (Table **[1](#T1){ref-type="table"}**). Notably, even at 40°C the reaction provided the \[^11^C\]carbamate **2** exclusively with no formation of *N*-\[^11^C-methyl\]-benzylamine (**3**). Thus, the results suggest that the high reactivity of \[^11^C\]CH~3~OTf enables alkylation to proceed to completion prior to decomposition of the carbamino adduct.

Using the optimized conditions for ^11^C-carbamate formation, *des*-carbamate-GR103545 \[[@R12]\] was converted to \[^11^C\]GR103545 in up to 91 ± 5% RCY (Table **[2](#T2){ref-type="table"}**). The carbamino adduct solution in DMF was found to effectively trap \[^11^C\]CH~3~OTf, with a volume of 100 μl sufficient to retain \> 90% of the total activity introduced. Using the reduced volume (100 μl) of the precursor solution in preparative runs \[[@R13]\], \[^11^C\]GR103545 was obtained in 85 ± 6% isolated RCY, with a specific activity of 1792 ± 312 mCi/μmol and radiochemical purity of \> 98%. The total synthesis time, including purification and formulation, was \< 25 min after end-of-bombardment (n = 8). The short synthesis time, high specific activity and excellent RCY achieved with this method should facilitate evaluation of the κ-OR tracer \[^11^C\]GR103545 in clinical trials.

CONCLUSION
==========

\[^11^C\]MeOTf has been shown to rapidly methylate carbamino adducts of primary and secondary amines, providing the corresponding ^11^C-carbamate groups in excellent yields under mild conditions (temperatures ≤ 40°C, 2 min reaction time). The utility of the method has been demonstrated by a highly efficient radiosynthesis of \[^11^C\]GR103545. The method is suitable for automated routine production using synthesis modules compatible with good manufacturing practice.

![Reaction of benzylamine with CO~2~ to form the carbamino adduct and alkylation with \[^11^C\]CH~3~I.](TOMCJ-2-72_S1){#S1}

###### 

Radiochemical Yield[a](#T1F1){ref-type="table-fn"} of *N*-benzyl-\[^11^C\]methyl Carbamate (2)[b](#T1F2){ref-type="table-fn"},[c](#T1F3){ref-type="table-fn"}

  Phase-Transfer Catalyst   Methylation Agent   T (°C)   Reaction Time (min)   RCY[a](#T1F1){ref-type="table-fn"}
  ------------------------- ------------------- -------- --------------------- ------------------------------------
  TBAI                      \[^11^C\]MeI        25       5                     36 ± 7
  TBAI                      \[^11^C\]MeI        40       5                     27 ± 6
  TBAI                      \[^11^C\]MeI        50       5                     21 ± 3
  TBAI                      \[^11^C\]MeI        70       5                     18 ± 4
  TBAOTf                    \[^11^C\]MeOTf      25       2                     69 ± 8
  TBAOTf                    \[^11^C\]MeOTf      25       5                     78 ± 6
  TBAOTf                    \[^11^C\]MeOTf      35       2                     82 ± 4
  TBAOTf                    \[^11^C\]MeOTf      40       2                     91 ± 5

Determined by analytical radio-HPLC

Results represent the mean ± sd, n = 4

To a solution of benzylamine (**1**) (2 mg, 18.6 µmol) in anhydrous DMF (500 µl) was added 3 molar equivalents of the TBA-reagent and 3 molar equivalents of Cs~2~CO~3~. CO~2~ gas (20 ml/min) was bubbled through the suspension for 1 h at room temperature. The ^11^C-alkylating agent was swept trapped in the reaction vial and allowed to react for the desired period of time.

###### 

Radiochemical Yield[a](#T2F1){ref-type="table-fn"} of \[^11^C\]GR103454[b](#T2F2){ref-type="table-fn"},[c](#T2F3){ref-type="table-fn"}

  ---- --- --------
  25   5   64 ± 5
  35   5   72 ± 6
  40   2   84 ± 4
  40   5   91 ± 5
  ---- --- --------

Determined by analytical radio-HPLC

Results represent the mean ± std, n = 5.

To a solution of *des*-carbamate-GR103545 (3 mg, 8.4 µmol) in anhydrous DMF (500 µl) was added 3 molar equivalents of the TBA-reagent and 3 molar equivalents of Cs~2~CO~3~. CO~2~ gas (20 ml/min) was bubbled through the suspension for 1 h at room temperature. Subsequently, the ^11^C-alkylating agent was swept trapped in the reaction vial and allowed to react for the desired period of time.
